- Home
- ACHV vs CGO Comparison
ACHV vs CGO Comparison
Compare ACHV & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- CGO
- Stock Information
- Founded
- ACHV N/A
- CGO 2004
- Country
- ACHV United States
- CGO United States
- Employees
- ACHV N/A
- CGO N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CGO Investment Managers
- Sector
- ACHV Health Care
- CGO Finance
- Exchange
- ACHV Nasdaq
- CGO Nasdaq
- Market Cap
- ACHV 131.2M
- CGO 114.2M
- IPO Year
- ACHV N/A
- CGO N/A
- Fundamental
- Price
- ACHV $2.68
- CGO $11.75
- Analyst Decision
- ACHV Strong Buy
- CGO
- Analyst Count
- ACHV 3
- CGO 0
- Target Price
- ACHV $14.33
- CGO N/A
- AVG Volume (30 Days)
- ACHV 2.0M
- CGO 34.7K
- Earning Date
- ACHV 08-07-2025
- CGO 01-01-0001
- Dividend Yield
- ACHV N/A
- CGO 9.25%
- EPS Growth
- ACHV N/A
- CGO N/A
- EPS
- ACHV N/A
- CGO N/A
- Revenue
- ACHV N/A
- CGO N/A
- Revenue This Year
- ACHV N/A
- CGO N/A
- Revenue Next Year
- ACHV N/A
- CGO N/A
- P/E Ratio
- ACHV N/A
- CGO N/A
- Revenue Growth
- ACHV N/A
- CGO N/A
- 52 Week Low
- ACHV $1.84
- CGO $7.90
- 52 Week High
- ACHV $5.31
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- ACHV 48.14
- CGO 61.55
- Support Level
- ACHV $2.58
- CGO $11.51
- Resistance Level
- ACHV $2.77
- CGO $11.77
- Average True Range (ATR)
- ACHV 0.18
- CGO 0.16
- MACD
- ACHV 0.05
- CGO -0.02
- Stochastic Oscillator
- ACHV 78.48
- CGO 86.27
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.